Thomas Dayspring/LinkedIn
Jul 27, 2026, 16:57
Thomas Dayspring։ Could PCSK9 Inhibitors Reduce the Risk of Retinal Vascular Occlusions?
Thomas Dayspring, Lipid Specialist, Educator at Early Medical, shared a post on LinkedIn about a recent article by Isabella H. Yazji et al, published in American Journal of Ophthalmology, adding:
”Of interest – The Impact of PCSK9 Inhibitors on Development of Retinal Vascular Occlusions.”
Title: The Impact of PCSK9 Inhibitors on Development of Retinal Vascular Occlusions
Authors: Isabella H. Yazji, Nadia J. Abbass, David C. Kaelber, Katherine E. Talcott, Rishi P. Singh
Stay updated on all scientific advances with Hemostasis Today.
-
Oct 26, 2026, 14:06Mokhtar Tazik: Evidence-Based Regulation to Strengthen Plasma Supply and Patient Safety
-
Oct 26, 2026, 13:57Gladys Delancey: Spotting the Warning Signs of Vein Disease
-
Oct 26, 2026, 13:36Kefah Mokbel: Targeted Breast Cancer Therapies Linked to Increased Thrombotic Risk
-
Oct 26, 2026, 13:32Jorge Enrique: Beyond Fibrin Targeting New Strategies for Thrombolysis
-
Oct 26, 2026, 13:23Priya Sriskandarajah: Treatment Challenges in Elderly and Frail Patients with Philadelphia-Negative MPNs
-
Oct 26, 2026, 12:48Milica Kuzmanovska: Latest Updates in PV, ET, and Myelofibrosis Management
-
Oct 26, 2026, 12:38Hytham Abu Aagla: Daratumumab and Transfusion Compatibility
-
Oct 26, 2026, 10:17Pankaj K.: Genetic Hemolytic Anemias Common Types, Symptoms and Long-Term Management
-
Oct 26, 2026, 10:09Christopher Robinson: Anemia and Postpartum Transfusion Rates at Different Blood Loss Thresholds After Vaginal Delivery